KEY FEATURES
| Full Name | Insulin |
|---|---|
| Synonym | IDDM2;ILPR;IRDN;MODY10; |
| Assay Type | Sandwich |
| Reactivity | Mouse |
| Range | 3.13-200pg/mL |
| Sensitivity | 1.88pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Mouse INS in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Mouse INS. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Mouse INS and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Mouse INS, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Mouse INS. You can calculate the concentration of Mouse INS in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Mouse INS ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 9.71 | 17.68 | 71.17 | 8.8 | 19.04 | 65.48 |
| Standard deviation | 0.63 | 0.81 | 2.82 | 0.53 | 0.88 | 2.8 |
| CV(%) | 6.48 | 4.58 | 3.96 | 6.01 | 4.64 | 4.28 |
RECOVERY
The recovery of Mouse INS spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 87-98 | 93 |
| EDTA plasma (n=8) | 93-108 | 101 |
| Cell culture media (n=8) | 87-97 | 92 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Mouse INS in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with PL ELISA Kits
| HLA-DQB1 ELISA Kit | publications with PL and HLA-DQB1 |
| INSR ELISA Kit | publications with PL and INSR |
| IGF1R ELISA Kit | publications with PL and IGF1R |
| GCK ELISA Kit | publications with PL and GCK |
| IDE ELISA Kit | publications with PL and IDE |
| SYTL4 ELISA Kit | publications with PL and SYTL4 |
Pathways associated with PL ELISA Kit
| ATF-2 Transcription Factor Network Pathway | ATF-2 Transcription Factor Network Pathway |
| Adipogenesis Pathway | Adipogenesis Pathway |
| Aldosterone-regulated Sodium Reabsorption Pathway | Aldosterone-regulated Sodium Reabsorption Pathway |
| Amyloids Pathway | Amyloids Pathway |
| Arf6 Trafficking Events Pathway | Arf6 Trafficking Events Pathway |
| Diabetes Pathways | Diabetes Pathways |
| Downstream Signaling Of Activated FGFR Pathway | Downstream Signaling Of Activated FGFR Pathway |
| FOXA1 Transcription Factor Network Pathway | FOXA1 Transcription Factor Network Pathway |
| FOXA2 And FOXA3 Transcription Factor Networks Pathway | FOXA2 And FOXA3 Transcription Factor Networks Pathway |
Diseases associated with PL ELISA Kit
| Kidney disorder involving deposition of calcium and oxalate or phosphate in the renal tubules | publications with PL and Kidney disorder involving deposition of calcium and oxalate or phosphate in the renal tubules |
| Neoplasms | publications with PL and Neoplasms |
| Diabetes Mellitus | publications with PL and Diabetes Mellitus |
| Cardiovascular Diseases | publications with PL and Cardiovascular Diseases |
| Kidney Diseases | publications with PL and Kidney Diseases |
| Diabetes Mellitus, Type 1 | publications with PL and Diabetes Mellitus, Type 1 |
| Pancreatic Neoplasms | publications with PL and Pancreatic Neoplasms |
| Insulin Resistance | publications with PL and Insulin Resistance |
| Adenoma | publications with PL and Adenoma |
| Diabetes Mellitus, Type 2 | publications with PL and Diabetes Mellitus, Type 2 |
Organs/Tissues associated with PL ELISA Kit
| Blood | publications with PL and Blood |
| Pancreas | publications with PL and Pancreas |
| Brain | publications with PL and Brain |
| Muscle | publications with PL and Muscle |
| Liver | publications with PL and Liver |
| Heart | publications with PL and Heart |
| Vascular | publications with PL and Vascular |
| Kidney | publications with PL and Kidney |
| Nerve | publications with PL and Nerve |
| Bone | publications with PL and Bone |